Indication
Squamous Cell Carcinoma in Situ
2 clinical trials
3 products
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)Status: Completed, Estimated PCD: 2022-08-24
Product
STP705Clinical trial
Combination of 5-Fluorouracil and Calcipotriene in the Treatment of Superficial Basal Cell Carcinomas and Squamous Cell Carcinomas in SituStatus: Recruiting, Estimated PCD: 2025-06-01
Product
5-Fluorouracil